Opzelura Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Opzelura
P
- pacritinib
- Philith (ethinyl estradiol / norethindrone)
- Pimtrea (desogestrel / ethinyl estradiol)
- Pirmella 1 / 35 (ethinyl estradiol / norethindrone)
- Pirmella 7 / 7 / 7 (ethinyl estradiol / norethindrone)
- Plan B One-Step (levonorgestrel)
- PMB (conjugated estrogens / meprobamate)
- Podprog Solution (minoxidil / progesterone topical)
- Portia (ethinyl estradiol / levonorgestrel)
- PostDay One-Step (levonorgestrel)
- Prefest (estradiol / norgestimate)
- Premarin (conjugated estrogens)
- Premarin Intravenous (conjugated estrogens)
- Premarin Vaginal (conjugated estrogens topical)
- Premphase (conjugated estrogens / medroxyprogesterone)
- Premphase 14 / 14 (conjugated estrogens / medroxyprogesterone)
- Prempro (conjugated estrogens / medroxyprogesterone)
- Preven EC (ethinyl estradiol / levonorgestrel)
- Preventeza (levonorgestrel)
- Previfem (ethinyl estradiol / norgestimate)
- Primogyn Depot (estradiol)
- Prochieve (progesterone)
- Progest (progesterone)
- Progestasert System (progesterone topical)
- progesterone
- progesterone topical
- Progynova (estradiol)
- Progynova TS (estradiol)
- Prometrium (progesterone)
- Provames (estradiol)
- Provera (medroxyprogesterone)
More about Opzelura (ruxolitinib topical)
- Opzelura consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- FDA approval history
- Drug class: topical antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.